Vertex Pharmaceuticals Incorporated (VIE:VRTX)
395.95
+1.80 (0.46%)
Last updated: Feb 4, 2026, 1:00 PM CET
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of €100 billion as of February 4, 2026. Its market cap has decreased by -5.30% in one year.
Market Cap
100.00B
Enterprise Value
91.39B
Revenue
9.99B
Ranking
n/a
PE Ratio
31.93
Stock Price
€395.95
Market Cap Chart
Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 73.88M to 100.00B, an increase of 135,249.08%. That is a compound annual growth rate of 23.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 100.00B | 2.08% |
| Dec 31, 2025 | 97.97B | -2.20% |
| Dec 31, 2024 | 100.17B | 5.60% |
| Dec 29, 2023 | 94.86B | 36.76% |
| Dec 30, 2022 | 69.36B | 41.28% |
| Dec 31, 2021 | 49.09B | -2.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Erste Group Bank AG | 42.84B |
| VERBUND AG | 21.12B |
| OMV Aktiengesellschaft | 16.23B |
| Raiffeisen Bank International AG | 14.25B |
| BAWAG Group AG | 10.79B |
| Strabag SE | 10.23B |
| Vienna Insurance Group AG | 8.68B |
| Andritz AG | 7.17B |